BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17471597)

  • 21. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
    Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
    J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of relapse in schizophrenia.
    Stalman SL
    N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987323
    [No Abstract]   [Full Text] [Related]  

  • 23. [Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
    Scherer J; Dobmeier P; Kuhn K; Schmaus W
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S167-9. PubMed ID: 15570542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Alzheimer's disease.
    Mahmoud R; Greenspan A
    N Engl J Med; 2004 Jan; 350(1):80-2; author reply 80-2. PubMed ID: 14708129
    [No Abstract]   [Full Text] [Related]  

  • 25. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of risperidone and donepezil in Lewy body dementia.
    Geizer M; Ancill RJ
    Can J Psychiatry; 1998 May; 43(4):421-2. PubMed ID: 9598283
    [No Abstract]   [Full Text] [Related]  

  • 27. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H
    J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat.
    Zhang X; Zhang Z; Cheng W; Mou X; Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):428-34. PubMed ID: 17050660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A biological basis for the sex bias of antipsychotic drugs adverse events.
    Gurwitz D; Morag A; Oved K
    J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Windhaber J; Urbanits S; Grisold W
    Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
    [No Abstract]   [Full Text] [Related]  

  • 32. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
    Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy for psychological symptoms of dementia--comparison between western and oriental medicine].
    Iwasaki K
    Fukuoka Igaku Zasshi; 2006 Mar; 97(3):53-4. PubMed ID: 16768175
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone versus haloperidol on secondary memory: can newer medications aid learning?
    Kern RS; Green MF; Marshall BD; Wirshing WC; Wirshing D; McGurk SR; Marder SR; Mintz J
    Schizophr Bull; 1999; 25(2):223-32. PubMed ID: 10416728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.
    Sultzer DL; Gray KF; Gunay I; Berisford MA; Mahler ME
    Am J Geriatr Psychiatry; 1997; 5(1):60-9. PubMed ID: 9169246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.